Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation

References

• HearingVJMilestones in melanocytes/melanogenesisJ Invest Dermatol2011131E1E122094398
   PubMedGoogle Scholar
• BrennerMHearingVJThe protective role of melanin against UV damage in human skinPhotochem Photobiol200884353954918435612
   PubMed Web of Science ®Google Scholar
• OlsonRLGaylorJEverettMASkin color, melanin, and erythemaArch Dermatol197310845415444745289
   PubMedGoogle Scholar
• HalderRMNoothetiPKEthnic skin disorders overviewJ Am Acad Dermatol200348Suppl 6S143S14812789168
   PubMed Web of Science ®Google Scholar
• TimilshinaSBhuvanKKhanalMMarshaniBPaudyalBSkalko-BasnetNThe influence of ethnic origin on the skin photoageing: Nepalese studyInt J Cosmet Sci201133655355921635272
   PubMed Web of Science ®Google Scholar
• ZoniosGBykowskiJKolliasNSkin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopyJ Invest Dermatol200111761452145711886508
   PubMed Web of Science ®Google Scholar
• Roméro-GrailletCAberdamEBiagoliNMassabniWOrtonneJ-PBallottiRUltraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytesJ Biol Chem19962714528052280568910416
   PubMed Web of Science ®Google Scholar
• SchwahnDJXuWHerrinABBalesESMedranoEETyrosine levels regulate the melanogenic response to α-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferationPigment Cell Res2001141323911277492
   PubMedGoogle Scholar
• KameyamaKTakemuraTHamadaYPigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitorJ Invest Dermatol199310021261318429235
   PubMed Web of Science ®Google Scholar
• SlominskiATobinDJShibaharaSWortsmanJMelanin pigmentation in mammalian skin and its hormonal regulationPhysiol Rev20048441155122815383650
   PubMed Web of Science ®Google Scholar
• TiefKHahneMSchmidtABeermannFTyrosinase, the key enzyme in melanin synthesis, is expressed in murine brainEur J Biochem1996241112168898882
   PubMedGoogle Scholar
• ChangTSAn updated review of tyrosinase inhibitorsInt J Mol Sci20091062440247519582213
   PubMed Web of Science ®Google Scholar
• ParvezSKangMChungHSSurvey and mechanism of skin depigmenting and lightening agentsPhytother Res2006201192193416841367
   PubMed Web of Science ®Google Scholar
• HermannsJPierard-FranchimontCPierardGSkin colour assessment in safety testing of cosmetics. An overviewInt J Cosmet Sci2000221677218503462
   PubMedGoogle Scholar
• KimSHHaYMMoonKMAnti-melanogenic effect of (Z)-5-(2, 4-dihydroxybenzylidene)thiazolidine-2,4-dione, a novel tyrosinase inhibitorArch Pharm Res201336101189119723812774
   PubMed Web of Science ®Google Scholar
• HaYMKimJAParkYJAnalogs of 5-(substituted benzylidene) hydantoin as inhibitors of tyrosinase and melanin formationBiochim Biophys Acta20111810661261921397665
   PubMed Web of Science ®Google Scholar
• MarksRThe stratum corneum barrier: the final frontierJ Nutr200413482017S2021S
   PubMed Web of Science ®Google Scholar
• MorpurgoGCatacuzzenoLPeruzziSBlasiPFiorettiBAre tyrosinase inhibitors in sunscreens and cosmetics enhancing UV carcinogenicity?Exp Dermatol201524754654725876676
   PubMed Web of Science ®Google Scholar
• MuÈllerRHMaÈderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• MüllerRHRadtkeMWissingSASolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev200254Suppl 1S131S15512460720
   PubMed Web of Science ®Google Scholar
• WissingSKayserOMüllerRSolid lipid nanoparticles for parenteral drug deliveryAdv Drug Deliv Rev20045691257127215109768
   PubMed Web of Science ®Google Scholar
• XuWLeeMKDevelopment and evaluation of lipid nanoparticles for paclitaxel delivery: a comparison between solid lipid nanoparticles and nanostructured lipid carriersJ Pharm Investig2015457675680
   Google Scholar
• AblaMJSinghNDBangaAKRole of nanotechnology in skin delivery of drugsPercutaneous Penetration Enhancers Chemical Methods in Penetration EnhancementVerlagBerlinHeidelbergSpringer2016113
   Google Scholar
• WissingSLippacherAMüllerRInvestigations on the occlusive properties of solid lipid nanoparticles (SLN)J Cosmet Sci2000525313324
   Web of Science ®Google Scholar
• AnsmannAKawaRNitscheMGondekHinventorsHenkel Kommanditgesellschaft Auf Aktien, assigneeContaining alkyl or alkenl oligoglycoside and fatty alcohol; cosmetics, drugsGoogle Patents US5795978 A1998818
   Google Scholar
• SoJWKimSParkJSPreparation and evaluation of solid lipid nanoparticles with JSH18 for skin-whitening efficacyPharma Dev Technol2010154415420
   PubMed Web of Science ®Google Scholar
• FanHLiuGHuangYLiYXiaQDevelopment of a nanostructured lipid carrier formulation for increasing photo-stability and water solubility of phenylethyl resorcinolAppl Surf Sci2014288193200
   Web of Science ®Google Scholar
• KiDHJungHCNohYWPreformulation and formulation of newly synthesized QNT3-18 for development of a skin whitening agentDrug Dev Ind Pharm201339452653322670797
   PubMed Web of Science ®Google Scholar
• ToktonNPanichayupakaranantPDevelopment of ellagic acid rich pomegranate extract loaded nanostructured lipid carriers (NLC)Int J Pharm Pharm Sci20146259265
   Google Scholar
• ZhangHZhangF-MYanS-JPreparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticlesInt J Nanomedicine201272901291022787390
   PubMed Web of Science ®Google Scholar
• SilvaAGonzález-MiraEGarcíaMPreparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasoundColloids Surf B Biointerfaces201186115816521530187
   PubMed Web of Science ®Google Scholar
• MüllerRDinglerAThe next generation after the liposomes: solid lipid nanoparticles (SLN, Lipopearls) as dermal carrier in cosmeticsEurocosmetics1998781926
   Google Scholar
• BrewerMSZhuLGBidnerBMeisingerDJMcKeithFKMeasuring pork color: effects of bloom time, muscle, pH and relationship to instrumental parametersMeat Sci200157216917622061360
   PubMed Web of Science ®Google Scholar
• KomatsuHKitajimaAOkadaSPharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopyChem Pharm Bull (Tokyo)1995438141214157553988
   PubMed Web of Science ®Google Scholar
• LevyMYSchutzeWFuhrerCBenitaSCharacterization of diazepam submicron emulsion interface: role of oleic acidJ Microencapsul199411179928138877
   PubMed Web of Science ®Google Scholar
• SchwarzCMehnertWSolid lipid nanoparticles (SLN) for controlled drug delivery II. Drug incorporation and physicochemical characterizationJ Microencapsul199916220521310080114
   PubMed Web of Science ®Google Scholar
• YoushiaJKamelAOEl ShamyAMansourSDesign of cationic nanostructured heterolipid matrices for ocular delivery of methazolamideInt J Nanomedicine201272483249622679362
   PubMed Web of Science ®Google Scholar
• VenkateswarluVManjunathKPreparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticlesJ Control Release200495362763815023472
   PubMed Web of Science ®Google Scholar
• ChenHChangXDuDPodophyllotoxin-loaded solid lipid nanoparticles for epidermal targetingJ Control Release2006110229630616325954
   PubMed Web of Science ®Google Scholar
• zur MühlenASchwarzCMehnertWSolid lipid nanoparticles (SLN) for controlled drug delivery – drug release and release mechanismEur J Pharm Biopharm19984521491559704911
   PubMed Web of Science ®Google Scholar
• BaekJ-SChoC-WComparison of solid lipid nanoparticles for encapsulating paclitaxel or docetaxelJ Pharm Investi2015457625631
   Google Scholar
• BawaRAudetteGFRubinsteinIHandbook of Clinical Nanomedicine: Nanoparticles, Imaging, Therapy, and Clinical Applications1Boca Raton, FL, USACRC Press2016
   Google Scholar
• WilliamsACBarryBWPenetration enhancersAdv Drug Deliv Rev201264128137
   Web of Science ®Google Scholar
• PanchagnulaRSalvePSThomasNSJainAKRamaraoPTransdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skinInt J Pharm20012191–29510511337170
   PubMed Web of Science ®Google Scholar
• OstrengaJSteinmetzCPoulsenBYettSSignificance of vehicle composition II: prediction of optimal vehicle compositionJ Pharm Sci1971608118011835127091
   PubMed Web of Science ®Google Scholar
• ChakrabortyAKFunasakaYSlominskiAUV light and MSH receptorsAnn N Y Acad Sci1999885110011610816644
   PubMedGoogle Scholar
• GilchrestBAParkHYEllerMSYaarMMechanisms of ultraviolet light-induced pigmentationPhotochem Photobiol19966311108577860
   PubMed Web of Science ®Google Scholar
• LinJYFisherDEMelanocyte biology and skin pigmentationNature2007445713084385017314970
   PubMed Web of Science ®Google Scholar
• HoglundEBalmPWinbergSSkin darkening, a potential social signal in subordinate arctic charr (Salvelinus alpinus): the regulatory role of brain monoamines and pro-opiomelanocortin-derived peptidesJ Exp Biol2000203111711172110804161
   PubMed Web of Science ®Google Scholar
• LevangAKZhaoKSinghJEffect of ethanol/propylene glycol on the in vitro percutaneous absorption of aspirin, biophysical changes and macroscopic barrier properties of the skinInt J Pharm1999181225526310370221
   PubMedGoogle Scholar
• ProphetEBMillsBArringtonJBSobinLHLaboratory Methods in HistotechnologyWashington, DC, USAAmerican Registry of Pathology1992
   Google Scholar
• NohynekGJAntignacEReTToutainHSafety assessment of personal care products/cosmetics and their ingredientsToxicol Appl Pharmacol2010243223925920005888
   PubMed Web of Science ®Google Scholar
• NurhasniHCaoJChoiMNitric oxide-releasing poly (lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activityInt J Nanomedicine2015103065308025960648
   PubMed Web of Science ®Google Scholar
• ZangeRKisselTComparative in vitro biocompatibility testing of polycyanoacrylates and poly (D, L-lactide-co-glycolide) using different mouse fibroblast (L929) biocompatibility test modelsEur J Pharm Biopharm1997442149157
   Web of Science ®Google Scholar
• MüllerRMaabenSWeyhersHMehnertWPhagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407J Drug Target1996431611708959488
   PubMed Web of Science ®Google Scholar
• HeydenreichAVWestmeierRPedersenNPoulsenHSKristensenHGPreparation and purification of cationic solid lipid nanospheres – effects on particle size, physical stability and cell toxicityInt J Pharm20032541838712615415
   PubMed Web of Science ®Google Scholar
• WeyenbergWFilevPVan den PlasDCytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal applicationInt J Pharm20073371–229129817300887
   PubMed Web of Science ®Google Scholar
• KwakSBriefELanglaisDKitsonNLafleurMThewaltJEthanol perturbs lipid organization in models of stratum corneum membranes: an investigation combining differential scanning calorimetry, infrared and 2H NMR spectroscopyBiochim Biophys Acta2012181851410141922366204
   PubMed Web of Science ®Google Scholar